CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 74  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.2419
LYS 10.0092
GLU 20.0219
LEU 30.0157
ARG 40.0235
CYS 50.0051
GLN 60.0074
CYS 70.0093
ILE 80.0210
LYS 90.0504
THR 100.0202
TYR 110.0122
SER 120.0218
LYS 130.0282
PRO 140.0129
PHE 150.0030
HIS 160.0158
PRO 170.0106
LYS 180.0260
PHE 190.0168
ILE 200.0066
LYS 210.0129
GLU 220.0064
LEU 230.0061
ARG 240.0100
VAL 250.0174
ILE 260.0178
GLU 270.0276
SER 280.0171
GLY 290.2419
PRO 300.1424
HIS 310.0241
CYS 320.0102
ALA 330.0140
ASN 340.0116
THR 350.0127
GLU 360.0102
ILE 370.0050
ILE 380.0082
VAL 390.0052
LYS 400.0092
LEU 410.0095
SER 420.0193
ASP 430.0179
GLY 440.0083
ARG 450.0105
GLU 460.0155
LEU 470.0093
CYS 480.0142
LEU 490.0071
ASP 500.0065
PRO 510.0023
LYS 520.0097
GLU 530.0091
ASN 540.0106
TRP 550.0059
VAL 560.0036
GLN 570.0111
ARG 580.0174
VAL 590.0038
VAL 600.0047
GLU 610.0089
LYS 620.0007
PHE 630.0038
LEU 640.0151
LYS 650.0103
ARG 660.0090
ALA 670.0156
GLU 680.0249
ASN 690.0136

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.